RLY-4008

ESMO: Relay spotlights expanded FGFR2 inhibitor data it hopes will pave accelerated approval
Fierce Biotech
Sun, 09/11/22 - 10:57 pm
ESMO
Relay Therapeutics
RLY-4008
cholangiocarcinoma
Relay Therapeutics’ Liver Cancer Approach Paying Early Dividends
BioSpace
Sat, 10/9/21 - 11:07 pm
Relay Therapeutics
RLY-4008
intrahepatic cholangiocarcinoma
liver cancer